Cervical Cancer Prophylaxis—State-of-the-Art and Perspectives
Background: Each year 604,127 new cases of cervical cancer (CC) are diagnosed, and 341,831 individuals die from the disease. It is the fourth most common cancer among women and the fourth most common cause of death from female cancers worldwide. The pathogenesis of CC is associated with human papill...
Main Authors: | Patryk Poniewierza, Grzegorz Panek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9032/10/7/1325 |
Similar Items
-
Cervical Cancer Prevention in the Era of the COVID-19 Pandemic
by: Patryk Poniewierza, et al.
Published: (2022-05-01) -
HPV-associated cervical cancer: Current status and prospects
by: E. A. Kravtsova, et al.
Published: (2023-07-01) -
Cervical cancer screening, treatment and prophylaxis in Brazil: Current and future perspectives for cervical cancer elimination
by: Flávia M. Corrêa, et al.
Published: (2022-08-01) -
CERVICAL CANCER ELIMINATION PROGRAM
by: D.R. Kaidarova, et al.
Published: (2021-06-01) -
Acceptability of deferring the start of cervical cancer screening to age 30 for women vaccinated against human papillomavirus
by: Gessica Martello, et al.
Published: (2023-12-01)